Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07634614Enrolling By Invitation

Pre- and Post-Therapy Evaluation of Air-Associated Symptoms in Patients With Gastro-esophageal Reflux Disease (GERD): Assessing the Role of Speech and Language Therapy

Role: lead

NCT05320796Phase 4Recruiting

The Bioavailability and Effect on Pouch pH of Esomeprazole After Gastric Bypass

Role: lead

NCT05132816Not ApplicableRecruiting

High Resolution Manometry After Partial Fundoplication for Gastro-oesophageal Reflux

Role: lead

NCT03025932Enrolling By Invitation

Recurrence Rate After Laparoscopic Repair of Large Hiatal Hernia

Role: lead

NCT06732050Not ApplicableCompleted

Influence of Intraoperative Nociception Guided Analgesia on Perioperative Total Analgesic Requirement Endometriosis

Role: lead

All 5 trials loaded